Abstract-Although the primary function of myoglobin (Mb) has been considered to be cellular oxygen storage and supply, recent studies have suggested to classify Mb as a multifunctional allosteric enzyme. In the heart, Mb acts as a potent scavenger of nitric oxide (NO) and contributes to the attenuation of oxidative damage. Here we report that a dynamic cycle exists in which a decrease in tissue oxygen tension drives the conversion of Mb from being an NO scavenger in normoxia to an NO producer in hypoxia. The NO generated by reaction of deoxygenated Mb with nitrite is functionally relevant and leads to a downregulation of cardiac energy status, which was not observed in mice lacking Mb. As a consequence, myocardial oxygen consumption is reduced and cardiac contractility is dampened in wild-type mice. We propose that this pathway represents a novel homeostatic mechanism by which a mismatch between oxygen supply and demand in muscle is translated into the fractional increase of deoxygenated Mb exhibiting enhanced nitrite reductase activity. Thus, Mb may act as an oxygen sensor which through NO can adjust muscle energetics to limited oxygen supply. (Circ Res. 2007;100:1749-1754.)
M yoglobin (Mb) is an important intracellular oxygen binding hemeprotein and one of the most widely studied proteins. The first pioneering review on Mb was published as early as 1939, in which Millikan concluded that "muscle hemoglobin" acts primarily as a short term oxygen store, tiding the muscle over from one contraction to the next. 1 In the past decade several additional biological functions were ascribed to Mb 2 and its molecular relative hemoglobin (Hb). Experiments with transgenic mice deficient in Mb have shown that Mb is an important scavenger of nitric oxide (NO) under normoxia 3, 4 which also protects the heart against reactive oxygen species. 4 Very recently, it has been reported that Hb participates in NO metabolism not only by oxidative inactivation, but also by the nonenzymatic NO formation from nitrite by deoxyHb. 5 This process is allosterically regulated by ambient oxygen pO 2 exhibiting maximal activity at the Hb P 50 . Despite total body concentration of Mb and Hb are similar, 6 a putative role of Mb in whole body metabolism of nitrite is unknown. Therefore, the aim of the present study was to elucidate (1) whether Mb acting as an NO scavenger under normoxic conditions may function as a relevant source of NO under hypoxia and (2) what functional consequences this Mb-derived NO may have on muscle function and energy metabolism.
Materials and Methods

Reaction of Mb With Nitrite
Horse Mb from Sigma was suspended in phosphate buffer saline (PBS) to a final concentration of 200 mol/L, according to the myocardial concentration of myoglobin. 7 Mb was deoxygenated by argon and oxygen saturation was measured spectrophotometrically. Nitrite was added to deoxygenated Mb and nitrosylated myoglobin (nitrosylMb) as a "dosimeter of NO formation" 8, 9 was measured by gas-phase-chemiluminescence using ferricyanide solution. 10 Further, hearts from mice were homogenated, deoxygenated, spiked with nitrite, and formation of NO was measured directly using gas-phase chemiluminescence. To characterize the impact of xanthineoxidoreductase and cytochrome on formation of NO, experiments with inhibitors were performed. Xanthine-oxidoreductase was inhibited by incubation of homogenate with 100 mol/L allopurinol to block the molybdenum-site and 200 mol/L diphenyliodonium to block the flavin-adenine dinucleotide-(FAD)-site. The electrontransfer from ubiquinol to bc 1 -complex in the mitochondrial respiratory chain was blocked by incubation with 300 mol/L myxothiazol.
NO Analysis of Cardiac Tissue
Tissue nitroso species (the sum of S-nitrosothiols and the mercurystable NO-adducts N-nitrosamines, iron-nitrosyles 11 ) and nitrite were determined applying group-specific reductive denitrosation by triiodine with subsequent detection of the NO liberated by gas-phasechemiluminescence. 11, 12 Nitrate was quantified after enzymatic reduction to nitrite by nitrate reductase using flow-injection analysis based on the Griess reaction. 13, 14 NO-heme was determined by parallel injection of replicate aliquots of tissue homogenates into a 0.05 mol/L ferricyanide solution to achieve 1-electron oxidation and quantify the liberated NO using gas-phase-chemiluminescence. 10 L-N(5)-(1-iminoethyl)-ornithine (L-NIO). 15 Preparation and perfusion of murine hearts of myo Ϫ/Ϫ7 and wt animals were performed essentially as described. 16 Until excision of the heart, animals received standard rodent chow. For NMR measurements, hearts were placed inside a 10-mm NMR tube, immersed in perfusion buffer (containing in mmol/L: NaCl 116, KCl 4.6, MgSO 4 1.1, NaHCO 3 24.9, CaCl 2 2.5, KH 2 PO 4 1.2, glucose 8.3, and EDTA 0.5), and transferred into a heated (37°C) 10-mm 1 H/ 31 P dual probe inside the spectrometer. Perfusion pressure, coronary flow, and left ventricular developed pressure (LVDP) were measured continuously. Signals were recorded with a sampling rate of 1000 Hz using a PC with dedicated software (Chart, AD Instruments). Arterial and venous pO 2 were measured simultaneously with implantable oxygen microsensors based on 140-m optical silica fiber (Presens) as previously described. 17 All hearts were initially perfused at constant coronary pressure with Krebs-Henseleit buffer equilibrated with 95% O 2 /5% CO 2 . After heart function had stabilized inside the magnet, cardiac pacing (500 bpm) was initiated and continued throughout. Left ventricular end-diastolic pressure was set to 5 mm Hg. Thirty minutes after the onset of cardiac pacing, coronary perfusion was fixed to the steady flow at which the hearts had stabilized. After the switch to constant flow, baseline data were recorded. Perfusion was then turned to buffer gassed at 50% O 2 /45% N 2 /5% CO 2 ( Figure 1 ) to induce partial deoxygenation of Mb and a normoxic buffer (95% O 2 / 5% CO 2 ) as control, respectively. Subsequently, solutions with increasing concentrations of nitrite (0.1; 1; 10; 100 mol/L) were infused stepwise, and in each section of the protocol hemodynamic data as well as NMR spectra were acquired.
P NMR Spectroscopy
Spectra were recorded at a Bruker DRX 400 WB NMR spectrometer, operating at frequencies of 400 MHz for 1 H and 161.97 MHz for 31 P. Shimming was done on the free induction decay of the water signal. A line width at half height of 15 Hz could be routinely obtained. Transients (nϭ240) were accumulated with a 75-degree flip angle, a repetition time of 1 second, a spectral width of 5682 Hz, a data size of 4K, zero filling to 8K, and exponential weighting resulting in a 10-Hz line broadening (4 minutes of signal accumulation). Chemical shifts were referenced to the phosphocreatine (PCr) resonance at Ϫ2.52 ppm. After baseline correction relative peak areas were obtained by integration and converted to concentrations as described before. 16 Calculated values for the free energy of adenosinetriphosphate (ATP) hydrolysis (⌬G ATP ) were derived from established relations.
Results
In a first step we determined whether free NO radicals can be formed from the reaction of nitrite and Mb in vitro. For this purpose nitrite was injected into an aqueous solution of Mb and the formed NO was analyzed by gas-phase-chemiluminescence. At 100% deoxygenated Mb and 10 mol/L nitrite the rate of NO production was determined to be 1.5Ϯ0.2 pmol/L/s. In contrast, in the absence of Mb or when Mb was fully oxygenated there was no detectable formation of NO. Similar to the findings reported for Hb these experiments show that the NO generated can escape from autoscavenging by the remaining heme group. 5 This becomes possible because the reaction with nitrite converts Mb to its ferric form (metMb, MbFe III ), which exhibits only limited NO scavenging properties.
To characterize the total amount of NO formed by reaction with Mb, consecutive reactions of NO have to be considered. In analogy to what has been reported for Hb, NO released from Mb can be captured by the remaining deoxygenated Mb (deoxyMb; MbFe II ) as nitrosylated Mb (nitrosyl-Mb; MbFe II -NO), which therefore can serve as an index of NO-formation. 9 Using the same gas-phase-chemiluminescence approach described above, but adding ferricyanide to liberate the Mb-bound NO, we found a substantial Mb-mediated formation of NO at physiologically relevant cytosolic levels of pO 2 and nitrite ( Figure 2A and 2B). The release of NO into the gas phase increased with the deoxygenation level of Mb and the concentration of nitrite.
We next analyzed the release of NO using murine myocardial tissue homogenates ( Figure 2C through 2E). The basal rate of NO formation from deoxygenated tissue homogenates in the presence of 100 mol/L nitrite was 2.5Ϯ0.3 nmol/g/s. In comparison, in homogenates from hearts of Mb-deficient (myo Ϫ/Ϫ ) mice the formation of NO was decreased by 60% as compared with wt controls ( Figure 2E ). Addition of Mb (200 mol/L final concentration) to myo Ϫ/Ϫ samples increased the formation of NO to levels of wt mice ( Figure 2E ). In contrast, inhibition of potential alternative nitrite-dependent NO producers, 18, 19 such as xanthine-oxidoreductase and the flavin-adenine dinucleotide-(FAD)-site by allopurinol and diphenyliodonium, respectively, did not reduce NO release ( Figure 2D ). Similarly, inhibition of the electron-transfer from ubiquinol to the bc 1 -complex in the mitochondrial respiratory chain by myxothiazol did not significantly reduce the formation of NO ( Figure 2C ).
The transport of intracoronarily applied nitrite into the myocardium has not been studied so far. To define the amounts of nitrite needed to increase endogenous levels, in a separate series of experiments we analyzed myocardial tissue content of nitrite. To differentiate between endogenous nitrite formation and the exogenously applied nitrite, NOS activity was inhibited with L-NIO 15 (5 times every 30 minutes before excision of hearts). Isolated perfused mouse hearts were then subjected to mild hypoxia (50% buffer O 2 ) which increases the fraction of deoxyMb to 50% and is associated with a cellular Po 2 of less than 4 mm Hg. 20 This was followed by replenishment of the nitrite pool during perfusion with increasing nitrite concentrations (0.1, 1, 10, 100 mol/L). Baseline cardiac nitrite levels were determined to be 2.96Ϯ0.42 mol/L, which were significantly reduced to 1.14Ϯ0.06 mol/L by application of L-NIO ( Figure  3A ; nϭ4, PϽ0.05). Perfusion with buffer containing 0.1 mol/L and 1 mol/L nitrite did not restore the initial cardiac nitrite levels (1.15Ϯ0.13 mol/L for 0.1 mol/L nitrite, Pϭn.s., and 1.59Ϯ0.36 mol/L for 1 mol/L nitrite, Pϭn.s.). Replenish- ment of the depleted tissue nitrite levels was only achieved by perfusion with concentrations Ն10 mol/L nitrite ( Figure 3A) . Buffer containing 10 mol/L nitrite led to cardiac nitrite levels of 2.54Ϯ0.75 mol/L, being close to basal values, whereas 100 mol/L nitrite increased tissue levels up to 2.5-fold above basal. Additional analysis of cardiac tissue NO content after nitrite application during hypoxia revealed a significant intracellular increase in nitroso-species and NO-heme products only at the level of 10 and 100 mol/L nitrite, respectively ( Figure 3A) . No increase in NO-heme and nitroso-species was seen in myo Ϫ/Ϫ mice ( Figure 3B) .
Having defined the changes in myocardial tissue nitrite levels we studied the functional consequences of the Mb-mediated NO formation from nitrite (for the full protocol see Figure 1 ). While stepwise increasing extracellular nitrite concentrations (0.1, 1, 10, 100 mol/L), hemodynamic analysis combined with 31 P NMR spectroscopy was performed in hearts from wt mice with myo Ϫ/Ϫ mice serving as appropriate controls. No changes were observed in both groups during perfusion with 0.1 and 1 mol/L nitrite. However, at extracellular concentrations Ն10 mol/L nitrite dosedependently increased myocardial inorganic phosphate (P i ) and decreased phosphocreatine (PCr) levels in wt hearts (Figure 4) , thereby reducing the free energy of ATP hydrolysis (⌬G ATP ). The impairment of the energy status was accompanied by a drop in left ventricular developed pressure and an increase of the coronary venous pO 2 in wt mice. Because hearts were perfused in the constant flow mode, an increase in coronary venous pO 2 reflects a reduced myocardial oxygen extraction and consumption ( Figure 5 ). Under the same conditions no changes in energetic or functional parameters were observed in hearts of myo Ϫ/Ϫ mice (Figures 4 and 5 ) (Figures 4 and 5 ). This equals a cellular pO 2 of less than 4 mm Hg as shown before. 20 After deoxygenation, nitrite (10 mol/L) was added. Increasing oxygenation of Mb is associated with decreasing formation of NO and thus nitrosyl-Mb. B, Concentrationdependent formation of nitrosyl-Mb. Nitrite (1 and 10 mol/L, respectively) was added to deoxygenated Mb solutions. The area shaded emphasizes the concentration range relevant for cardiomyocytes. C through E, Cardiac Mb converts nitrite. Heart-homogenates of wild-type and myo Ϫ/Ϫ mice (300 g protein) were added to a solution of deoxygenated nitrite (100 mol/L at pH 5 and 37°C), and the subsequent formation of NO was measured by gas phase chemiluminescence. Where required, inhibitors were added 30 minutes before addition to nitrite-solution. Inhibition of xanthine-oxidoreductase by incubation of homogenate with 100 mol/L allopurinol to block the molybdenum-site and 200 mol/L diphenyliodonium (dpi) to block the flavin-adenine dinucleotide-(FAD)-site (C) and inhibition of the electrontransfer from ubiquinol to bc 1 
Discussion
The results of the present study demonstrate that under hypoxic conditions Mb transforms from an NO scavenger to a potent NO producer. DeoxyMb converts nitrite to NO, which then interacts in a reversible manner with myocytic cytochromes and downregulates cardiac energy status. This leads to a reduction in oxygen consumption and consecutively also of cardiac contractility. The increased inorganic phosphate levels caused by the enhanced breakdown of PCr may furthermore be an additional and important link between energetics and contractility. 21 Together, these reactions may represent a crucial endogenous protecting mechanism for the heart.
It is well known that cardiac contractile function and energy metabolism are actively downregulated, when coronary blood supply is critically reduced and this "perfusion-contraction matching" is a unique feature of the heart. 22 On acute coronary artery inflow reduction, contractile function of the ischemic region is rapidly decreased and is associated with a decrease in oxygen consumption. This dampens the fall in high energy phosphates and over time even can restore myocardial energy balance. The mechanisms underlying this adaptive response, termed short-term hibernation, remained largely unclear until now. On nitrite infusion we observe a scenario which strongly resembles the characteristics described for acute hibernation: a decrease in PCr, a concomitant increase in P i , and a reduction of the available driving force for all energy-consuming processes (⌬G ATP ). Furthermore, we provide evidence for a reduction of ATP utilization (decrease in left ventricular developed pressure) and ATP synthesis (decrease in myocardial oxygen consumption) during nitrite infusion. Obviously, a new steady state for ATP is reached and ATP levels are maintained at lower steady state levels of PCr. Therefore, the pO 2 -dependent nonenzymatic formation of NO by reaction of Mb with nitrite may represent an important causal factor of short-term hibernation. Although the presented experiments were performed under hypoxic perfusion conditions which cause Mb to be deoxygenated by about 50%, low-flow ischemia certainly can further lower tissue pO 2 , thereby further augmenting the ability of deoxymyglobin to form NO from nitrite. 23 It is noteworthy that Martin et al 24 recently provided evidence for a NO synthase-independent NO formation during myocardial ischemia, which can be easily explained on the basis of the present work.
Published experimental studies support our findings that under hypoxic conditions myoglobin may react with nitrite to form NO, 25 and that this reaction may play a crucial role in the regulation of physiological functions. 26 Similar to the present work, Shiva et al have most recently demonstrated that in isolated cardiomyocytes the nitrite reductase activity of deoxymyoglobin releases NO in proximity to mitochondria and regulates respiration through cytochrome c oxidase. 27 Furthermore, different groups have shown that the application of low doses of nitrite prevents ischemia/reperfusioninjury in the Langendorff heart model 18 as well as in the liver and heart of mice. 28 The xanthine-oxidoreductase dependent reduction of nitrite to NO 18 and a deoxyhemoglobin-and myoglobinmediated nitrite reduction to NO 27, 28 have been proposed as poten- tial mechanisms, but we ( Figure 2C and 2D) and others 27 were not able to show a significant role for xanthine-oxidoreductase in reducing nitrite.
Our data may be criticized that rather high extracellular concentrations of nitrite (10 to 100 mol/L) were required to elicit the biological response. However, it is the intracellular concentration of nitrite which is of critical importance for the reaction with deoxyMb. Pretreatment of animals with the NOS inhibitor NIO decreased cytosolic nitrite by approximately 70%, and perfusion with concentrations Ն10 mol/L nitrite was required to replenish the myocytic levels to the range of untreated controls. Obviously, comparatively high extracellular nitrite concentrations have to be applied under our experimental conditions to mimic the in vivo conditions with unrestricted activity of NOS and unlimited availability of its substrate arginine which was deliberately not supplemented with the perfusion buffer. Together our data suggest that the effect of nitrite on cardiac function occurred at physiological cytosolic nitrite concentrations.
NO formation by deoxyMb may not only be relevant for the heart, but it also could contribute to hypoxic vasodilation described for the human circulation. 5 As already pointed out above, the total body amounts of Hb and Mb are similar so that the ability of both proteins to act as nitrite-reductase might have been involved in the vasodilation of the exercising muscle previously reported. Using 1 H NMR spectroscopy the fraction of deoxyMb in skeletal muscle of healthy humans was found to be 9%. 29 On exercise (50 to 60% of maximum work rate) the deoxyMb signal increases to about 50%, corresponding to an intracellular pO 2 lower than 5 mm Hg. 30 This is similar to values obtained in the present study with hypoxic perfusion of the heart. Using quadriceps maximum isometric voluntary torque and measuring PCr and deoxyMb by interleaved 1 H and 31 P NMR spectroscopy, the fraction of deoxyMb was found to increase up to 70%, whereas PCr reversibly decreased to 20% of control. 31 Given this significant deoxygenation of Mb in human exercising muscle, this most likely has profoundly increased the Mbmediated formation of NO (Figure 2) . Because of the low diffusion distances between Mb and mitochondria, this NO may be critically involved in the observed inhibition of oxidative phosphorylation, which is known to be extremely NO sensitive. 32 This mechanism may therefore play an important role in limiting muscle oxygen consumption and thus the exercise capacity of skeletal muscle.
In summary this study describes a novel homeostatic mechanism by which a mismatch between oxygen supply and demand is translated into the fractional increase of deoxyMb exhibiting enhanced nitrite reductase activity. DeoxyMb may act as an important oxygen sensor through which NO can regulate muscle energetics and function. This appears to be functionally important in the infarcted heart, during acute myocardial hibernation, and intense muscle exercise. 
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